Condensed Balance Sheets - USD ($)		Jun. 30, 2022	Dec. 31, 2021
Current Assets
Cash		$ 1,229,516
Deferred offering costs		6,063,827	$ 494,650
Other assets - current		530,972
Total Current Assets		1,760,487	494,650
Other assets - noncurrent		437,805
Marketable securities held in Trust Account		266,774,496
Total Assets		268,972,789	494,650
Current Liabilities
Accounts payable		210,590
Accrued expense		75,631
Accrued offering costs			147,472
Due to Sponsor		56,275	325,765
Total current liabilities		342,496	473,237
Warrant liability		4,353,750
Total Liabilities		4,696,246	473,237
Commitments and Contingencies (Note 6)
Shareholders' (Deficit) Equity
Additional paid in capital			24,353
Accumulated deficit		(2,498,600)	(3,587)
Total Shareholders' (Deficit) Equity		(2,497,953)	21,413
TOTAL LIABILITIES, REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS' (DEFICIT) EQUITY		268,972,789	494,650
Class A Ordinary Shares
Current Liabilities
Ordinary shares		266,774,496
Class B Ordinary Shares
Shareholders' (Deficit) Equity
Common stock	[1]	$ 647	$ 647

[1] On March 22, 2022, the Company surrendered 718,750 shares of Class B ordinary shares as a result of updated terms of the proposed public offering. All share amounts and related information have been retroactively restated to reflect the surrender. Includes an aggregate of up to 843,750 shares that are subject to forfeiture if the over-allotment option is not exercised in full by the underwriter (see Note 8). On May 12, 2022, the underwriter exercised the full over-allotment option.